Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

THC Biomed Intl Ltd. THCBF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
12/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

THC Biomed Intl Ltd. (THCBF) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 11/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is -30.8% (-108.4 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 33/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

THCBF SharesGrow Score Overview

24/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — THCBF

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
THCBF: -40.4%/yr revenue is, -1227.9%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet THCBF: Debt-to-Equity (D/E) ratio N/A, Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.001-0.0245
Volume394
Avg Volume (30D)1.04K
Market Cap$205.02K
Beta (1Y)-0.36
Share Statistics
Shares Outstanding$163.94M
IPO Date2018-03-16
Employees35
CEOJohn Miller
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryCA
ExchangeOther OTC
CurrencyUSD
ISINCA87243W1032

Price Chart

Track all markets on TradingView
THCBF
THC Biomed Intl Ltd. ↗  ·  Other OTC
Healthcare • Drug Manufacturers - Specialty & Generic
0.00 52WK RANGE 0.02

People Also View

ETST
ETST
Earth Science Tech, Inc.
$0.13
+6.50%
 ITHUF
ITHUF
iAnthus Capital Holdings, Inc.
$0.00
+5.52%
 RAMMF
RAMMF
RAMM Pharma Corp.
$0.06
+0.00%
 MCUJF
MCUJF
Medicure Inc.
$0.96
+0.00%
 UBQU
UBQU
Ubiquitech Software Corp.
$0.00
+0.00%
 CVGRF
CVGRF
City View Green Holdings Inc.
$0.03
-4.57%
 IMCC
IMCC
IM Cannabis Corp.
$0.38
+4.79%
 CSTF
CSTF
CuraScientific Corp
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message